A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes

To assess the efficacy and safety of DPP-4 inhibition with sitagliptin in youth with type 2 diabetes (T2D). Study Design This was a 54-week, double-blind, randomized, controlled clinical trial evaluating the safety and efficacy of DPP-4 inhibition with sitagliptin 100 mg once daily as initial oral t...

Full description

Saved in:
Bibliographic Details
Main Authors: Shankar, R. Ravi, Zeitler, Philip, Deeb, Asma, Jalaludin, Muhammad Yazid, Garcia, Raymundo, Newfield, Ron S., Samoilova, Yulia, Rosario, Carmen A., Shehadeh, Naim, Saha, Chandan K., Zhang, Yilong, Zilli, Martina, Scherer, Lynn W., Lam, Raymond L. H., Golm, Gregory T., Engel, Samuel S., Kaufman, Keith D.
Format: Article
Published: Wiley 2022
Subjects:
Online Access:http://eprints.um.edu.my/33637/
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items